» Articles » PMID: 38676895

Porcine Model of Hypertrophy-Independent Left Ventricular Stiffening Via Repetitive Pressure Overload

Overview
Specialty Molecular Biology
Date 2024 Apr 27
PMID 38676895
Authors
Affiliations
Soon will be listed here.
Abstract

Diastolic dysfunction arising from alterations in myocardial structure and/or function is a central component of several cardiovascular disorders, including heart failure with preserved ejection fraction (HFpEF). Basic research aimed at understanding underlying mechanisms contributing to the development of diastolic dysfunction has generally centered upon models of left ventricular (LV) hypertrophy arising from persistent and severe elevations in myocardial afterload (e.g., aortic banding). Mechanisms of hypertrophy-independent diastolic dysfunction, on the other hand, have received less attention, even though overt anatomic LV hypertrophy is absent in many HFpEF patients. Here, we describe the development of a novel porcine model of repetitive pressure overload (RPO) in which chronic, intermittent exposure to transient episodes of hypertension produces an increase in LV stiffness, interstitial fibrosis, cardiomyocyte hypertrophy, and capillary rarefaction without significant changes in LV mass. This model offers important insight into how diastolic dysfunction and HFpEF may develop in the absence of comorbidities, sustained hypertension, or LV hypertrophy, while also providing a useful translational research tool for investigation of novel therapeutic approaches to restore myocardial compliance and improve diastolic function.

References
1.
Butler J, Fonarow G, Zile M, Lam C, Roessig L, Schelbert E . Developing therapies for heart failure with preserved ejection fraction: current state and future directions. JACC Heart Fail. 2014; 2(2):97-112. PMC: 4028447. DOI: 10.1016/j.jchf.2013.10.006. View

2.
Sharma K, Kass D . Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ Res. 2014; 115(1):79-96. PMC: 4146618. DOI: 10.1161/CIRCRESAHA.115.302922. View

3.
Borlaug B, Nishimura R, Sorajja P, Lam C, Redfield M . Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail. 2010; 3(5):588-95. PMC: 3048586. DOI: 10.1161/CIRCHEARTFAILURE.109.930701. View

4.
Redfield M . Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2016; 375(19):1868-1877. DOI: 10.1056/NEJMcp1511175. View

5.
Paulus W, Tschope C . A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013; 62(4):263-71. DOI: 10.1016/j.jacc.2013.02.092. View